Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Angina Pectoris/MI
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Angina Pectoris/MI
    Clopidogrel Gets Boxed Warning for Reduced Effectiveness in Certain Patients - (DGNews)
    TopAbstracts in Angina Pectoris/MI 03/03/2010 - (DGNews)
    Ischaemic Conditioning Prevents Damage After Myocardial Infarction - (DGNews)
    Fatigue May Predict Cardiovascular Outcomes in Patients Undergoing Haemodialysis - (DGNews)
    TopAbstracts in Angina Pectoris/MI 02/17/2010 - (DGNews)

    News archive

     Recent webcasts/CME - Angina Pectoris/MI
      Keys to Successful Outcomes from Anticoagulant and Antiplatelet Therapy: Addressing Medication Therapy Management Issues
      Cardiovascular Series: Guidelines for Anticoagulant and Antiplatelet Therapy in the Prevention and Treatment of Acute Coronary Syndrome: Incorporation into Clinical Practice
      Translating Evidence-Based Guidelines into Clinical Practice in the Management of Acute Coronary Syndrome
      Anti-inflammatory and Anti-atherogenic Effects of Insulin
      ST-Elevation Myocardial Infarction: A Case Study

      Webcasts/CME archive

       Recent cases - Angina Pectoris/MI
        Acute Myocardial Infarction As The First Presentation Of Thyrotoxicosis In A 31-Year Old Woman - Case Report
        Late Restenosis Related To Cypher Stent Fracture
        Acute Perimyocarditis Mimicking Transmural Myocardial Infarction
        Successful Percutaneous Intervention to Acute Myocardial Infarction Presenting With Typical Chest Pain in Transplanted Heart
        Dual Antiplatelet Therapy in Coronary Artery Disease: A Case-Based Approach

        Cases archive
          




        my personal edition > angina pectoris/mi > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Diltiazem Prevents Death and Myocardial Infarction during Non-cardiac Surgery: Presented at AHA

        By Jill Stein

        CHICAGO, IL -- November 26, 2002 -- The calcium channel blocker diltiazem significantly reduces the frequency of cardiac complications during non-cardiac surgery, suggest new data reported here November 20 at the 2002 Scientific Sessions of the American Heart Association (AHA).

        Dr. Duminda N. Wijeysundera, with the University of Toronto, in Toronto, Ontario, Canada, presented the results of a meta-analysis of all randomized controlled trials evaluating calcium channel blockers in non-cardiac surgery available on MEDLINE (1966 through December 2001) and EMBASE (1980 through December 2001).

        "Cardiac complications following non-cardiac surgery increase mortality, morbidity, and healthcare costs," Dr. Wijeysundera pointed out. "Calcium channel blockers may improve the balance between myocardial oxygen demand and supply. Their role in preventing perioperative complications, however, remains unclear."

        The 15 trials included in the meta-analysis (with a total of 992 patients) compared calcium channel blockers to non-calcium channel blockers during non-cardiac surgery and reported any of the following outcomes: death, myocardial infarction (MI), ischemia, and supraventricular tachyarrhythmias (SVT). The analysis excluded studies with patients who were organ transplant recipients, who had undergone cerebral aneurysm repair, and who had been treated for SVT.

        Calcium channel blockers significantly reduced ischemia (risk ratio [RR] 0.48, p=0.004) and SVT (RR= 0.51, p=0.00007), and were associated with trends towards decreased death (RR 0.25, p=0.07) and MI (RR 0.25, p=0.08).

        Given the small number of outcomes, the researchers performed post hoc analyses using combined end points. Calcium channel blockers reduced major morbid events, which included death, myocardial infarction, congestive heart failure (RR 0.2, p=0.04) and death/MI (RR 0.24, p=0.02).

        Diltiazem reduced ischemia (RR 0.34, p=0.00005), SVT (RR 0.54, p=0.00009), major morbid events (RR0.27, p=0.02), and death/MI (RR0.26, p=0.02).

        Dr. Wijeysundera said results of this meta-analysis justify further study of perioperative calcium channel blockers, especially diltiazem, in a large, high-quality, double-blinded, randomized, controlled trial.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send